Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Freddy A. JimenezSVP & General Counsel | Celldex TherapeuticsCLDX | Open-market sale | 25/12/04 | 25/12/08 | 4,166 sh | $29.10 | $121,230.6 | −11.9% |
Richard M. WrightOther | Celldex TherapeuticsCLDX | Open-market sale | 25/11/13 | 25/11/17 | 49,298 sh | $24.00 | $1,183,152 | −70.3% |
Celldex TherapeuticsCLDX | Open-market sale | 25/08/13 | 25/08/15 | 771 sh2 trades | $24.77avg. | $19,097.55 | −2.2% | |
Anthony S. MarucciPresident & CEO | Celldex TherapeuticsCLDX | Open-market buy | 24/11/11 | 24/11/12 | 11,500 sh | $26.82 | $308,430 | +40.0% |
Elizabeth CrowleySr. Vp & Cpdo | Celldex TherapeuticsCLDX | Open-market sale | 24/06/14 | 24/06/18 | 30,000 sh | $34.87 | $1,046,100 | −76.8% |
Samuel Bates MartinSVP and CFO | Celldex TherapeuticsCLDX | Open-market sale | 24/06/14 | 24/06/18 | 17,172 sh | $35.42 | $608,232.24 | −37.9% |
Diane C. YoungSVP, Chief Medical Officer | Celldex TherapeuticsCLDX | Open-market sale | 24/06/07 | 24/06/11 | 45,000 sh | $35.26 | $1,586,700 | −95.5% |
Elizabeth CrowleySr. Vp & Cpdo | Celldex TherapeuticsCLDX | Open-market sale | 24/06/07 | 24/06/11 | 15,000 sh | $35.06 | $525,900 | −62.3% |
Celldex TherapeuticsCLDX | Open-market sale | 24/06/03 | 24/06/05 | 46,844 sh2 trades | $33.72avg. | $1,579,540.76 | −69.2% | |
Margo Heath-ChiozziSVP of Regulatory Affairs | Celldex TherapeuticsCLDX | Open-market sale | 24/06/03 | 24/06/05 | 58,369 sh | $33.65 | $1,964,116.85 | −81.3% |
Freddy A. JimenezSVP & General Counsel | Celldex TherapeuticsCLDX | Open-market sale | 24/06/03 | 24/06/05 | 8,006 sh | $33.60 | $269,001.6 | −23.6% |
Elizabeth CrowleySr. Vp & Cpdo | Celldex TherapeuticsCLDX | Open-market sale | 24/05/30 | 24/06/03 | 38,597 sh | $33.64 | $1,298,403.08 | −81.0% |
Samuel Bates MartinSVP and CFO | Celldex TherapeuticsCLDX | Open-market sale | 24/05/30 | 24/06/03 | 35,000 sh | $34.05 | $1,191,750 | −58.2% |
Sarah CavanaughSVP of Corp Affairs & Admin | Celldex TherapeuticsCLDX | Open-market sale | 24/05/30 | 24/06/03 | 20,853 sh | $33.73 | $703,371.69 | −91.8% |
Margo Heath-ChiozziSVP of Regulatory Affairs | Celldex TherapeuticsCLDX | Open-market sale | 24/05/30 | 24/06/03 | 38,719 sh | $34.07 | $1,319,156.33 | −84.5% |